ID: ALA3747123

Max Phase: Preclinical

Molecular Formula: C15H14N2O2

Molecular Weight: 254.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)cc2oc3cc(N(C)C)ccc3nc1-2

Standard InChI:  InChI=1S/C15H14N2O2/c1-9-6-11(18)8-14-15(9)16-12-5-4-10(17(2)3)7-13(12)19-14/h4-8H,1-3H3

Standard InChI Key:  ZRHNNMZRNKBRSI-UHFFFAOYSA-N

Associated Targets(Human)

Dickkopf-related protein 1/Low-density lipoprotein receptor-related protein 6 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.29Molecular Weight (Monoisotopic): 254.1055AlogP: 2.67#Rotatable Bonds: 1
Polar Surface Area: 46.34Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.05CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.63Np Likeness Score: -0.53

References

1. Mpousis S, Thysiadis S, Avramidis N, Katsamakas S, Efthimiopoulos S, Sarli V..  (2016)  Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathies.,  108  [PMID:26629858] [10.1016/j.ejmech.2015.11.024]

Source